Fundz

Who to call at OncoNano Medicine, and when

Fundz watches for the moments OncoNano Medicine starts buying, and tells you who to reach.

  • An alert the day OncoNano Medicine raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OncoNano Medicine, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OncoNano Medicine. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

OncoNano Medicine and Gilead Sciences Enter Research Collaboration for ON-BOARD™ Technology on Gilead’s Drug Candidate.

Jan 06, 2026

Contract Type

partnership

SouthlakeBiotechnologyHealth CareMedicalTherapeutics

Description

OncoNano Medicine has announced a research collaboration with Gilead Sciences to evaluate the effectiveness of its ON-BOARD™ delivery technology with Gilead's drug candidate. The agreement includes opportunities for milestone payments and royalties based on the success of the collaboration.

Quick answer

OncoNano Medicine and Gilead Sciences Enter Research Collaboration for ON-BOARD™ Technology on Gilead’s Drug Candidate. (January 6, 2026). OncoNano Medicine is based in Southlake, Texas, United States.

What agreement did OncoNano Medicine announce on January 6, 2026?
OncoNano Medicine has announced a research collaboration with Gilead Sciences to evaluate the effectiveness of its ON-BOARD™ delivery technology with Gilead's drug candidate. The agreement includes opportunities for milestone payments and royalties based on the success of the collaboration.
What does OncoNano Medicine do?
OncoNano is harnessing the power of nanotechnology to unlock a new era of targeted therapeutics.
Where is OncoNano Medicine based?
OncoNano Medicine is based in Southlake, Texas, United States.

Source: Fundz verified event record.

Company Information

Company

OncoNano Medicine

Location

3060 Pegasus Park Drive

Southlake, Texas, United States

About

OncoNano is harnessing the power of nanotechnology to unlock a new era of targeted therapeutics. Our ON-BOARD™ polymeric micelle platform exploits the highly acidic tumor microenvironment, a byproduct of cancer metabolism, to precisely deliver therapeutic payloads directly to the tumor site. OncoNano’s product candidates are designed to improve the pharmacokinetic and pharmacodynamic properties of various payloads from small molecules to large biologics through encapsulation and localized tumor targeting.

Related People

Matthew
Likely contact at this company
••••••••@••••••••

See Matthew's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for OncoNano Medicine's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

OncoNano Medicine signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.